Epsilon HealthcareASX:EPN Receivables Turnover is 5.00 as of Dec. 2025. The stock has 4 warning signs investors should review. Among 947 Drug Manufacturers companies, Epsilon Healthcare ranks better than 81.73% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Epsilon Healthcare's Revenue for the
six
months ended in Dec. 2025 was A$5.99 Mil. Epsilon Healthcare's average Accounts Receivable for the
six
months ended in Dec. 2025 was A$1.20 Mil.
Hence, Epsilon Healthcare's Receivables Turnover for the
six
months ended in Dec. 2025 was 5.00.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Epsilon Healthcare Receivables Turnover Related Terms
Epsilon Healthcare Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Epsilon Healthcare's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:EPN vs ZTS, UTHR: Receivables Turnover Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Epsilon Healthcare's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Epsilon Healthcare Receivables Turnover vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Epsilon Healthcare's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Epsilon Healthcare's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Epsilon Healthcare (ASX:EPN) has a Receivables Turnover of 5.00 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Epsilon Healthcare and its competitors. According to the industry distribution chart, Epsilon Healthcare ranks #173 out of 947 companies in the Drug Manufacturers industry, placing it in the top 18.3%.
Is Epsilon Healthcare's Receivables Turnover too high?
Epsilon Healthcare's current Receivables Turnover is 5.00. The Drug Manufacturers industry median Receivables Turnover is 5.07. Epsilon Healthcare's value of 5.00 is 1.4% below this industry median. Based on the distribution chart, Epsilon Healthcare ranks #173 out of 947 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Epsilon Healthcare's Receivables Turnover compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Epsilon Healthcare ranks #173 out of 947 companies for Receivables Turnover. This places Epsilon Healthcare in the top 18% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.07. Epsilon Healthcare's value of 5.00 is 1.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Drug Manufacturers company?
The median Receivables Turnover among Drug Manufacturers companies is 5.07, based on 947 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Epsilon Healthcare's current Receivables Turnover of 5.00 is 1.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Epsilon Healthcare and its competitors. For the Drug Manufacturers industry, the median Receivables Turnover is 5.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Epsilon Healthcare's current Receivables Turnover is 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epsilon Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Epsilon Healthcare (ASX:EPN) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.02 — trading 26.7% below its estimated fair value. The current Receivables Turnover is 5.00 and 1.4% below the Drug Manufacturers industry median of 5.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Epsilon Healthcare (ASX:EPN), the current Receivables Turnover is 5.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Epsilon Healthcare Ltd is an Australian based, globally active healthcare organisation. It operates a diversified and vertically integrated portfolio of assets, including healthcare and clinics operation, pharmaceutical contract development and manufacturing operation & pharmacy services. The company offers end-to-end solutions across the healthcare spectrum: from product development and manufacturing to patient care. The company's three (3) main operating segments are: a. Contract Development and Manufacturing activities, b. Telehealth medical practice services; and c. Pharmacy services. The majority of revenue is derived from the Contract Development and Manufacturing activities segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EPN has been successfully added to your 